Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

148 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The PROSPECT Is Bright for CFTR Modulators.
Montemayor K, Lechtzin N. Montemayor K, et al. Among authors: lechtzin n. Ann Am Thorac Soc. 2021 Jan;18(1):32-33. doi: 10.1513/AnnalsATS.202007-881ED. Ann Am Thorac Soc. 2021. PMID: 33385230 Free PMC article. No abstract available.
Cystic fibrosis transmembrane conductance regulator modulators reduce the risk of recurrent acute pancreatitis among adult patients with pancreas sufficient cystic fibrosis.
Akshintala VS, Kamal A, Faghih M, Cutting GR, Cebotaru L, West NE, Jennings MT, Dezube R, Whitcomb DC, Lechtzin N, Merlo CA, Singh VK. Akshintala VS, et al. Among authors: lechtzin n. Pancreatology. 2019 Dec;19(8):1023-1026. doi: 10.1016/j.pan.2019.09.014. Epub 2019 Sep 28. Pancreatology. 2019. PMID: 31611131
Unmasking catamenial hemoptysis in the era of CFTR modulator therapy.
Montemayor K, Claudio AT, Carson S, Lechtzin N, Christianson MS, West NE. Montemayor K, et al. Among authors: lechtzin n. J Cyst Fibros. 2020 Jul;19(4):e25-e27. doi: 10.1016/j.jcf.2020.01.005. Epub 2020 Jan 24. J Cyst Fibros. 2020. PMID: 31987762 Free PMC article.
Long-term safety and efficacy of tezacaftor-ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND): an open-label extension study.
Flume PA, Biner RF, Downey DG, Brown C, Jain M, Fischer R, De Boeck K, Sawicki GS, Chang P, Paz-Diaz H, Rubin JL, Yang Y, Hu X, Pasta DJ, Millar SJ, Campbell D, Wang X, Ahluwalia N, Owen CA, Wainwright CE; VX14-661-110 study group. Flume PA, et al. Lancet Respir Med. 2021 Jul;9(7):733-746. doi: 10.1016/S2213-2600(20)30510-5. Epub 2021 Feb 10. Lancet Respir Med. 2021. PMID: 33581080
148 results